An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
To Construct an Interpretable Multi-modal Report Generating System For Fundus Diseases Based On Weakly Labelings
1 other identifier
observational
9,999
1 country
1
Brief Summary
To establish a multimodal fundus image report generation model to realize an interpretable system for multiple fundus diseases, multimodal image analysis, diagnosis, and treatment decision automatic reporting based on weakly labeled training data. Construct an interpretable feature fusion network for the clinical and imaging features of fundus lesions, and we hope to extract new imaging markers that can predict the occurrence and progression of various fundus lesions at an early stage, and ultimately verify them in real clinical data, further providing possible directions for exploring the molecular mechanisms of refractory fundus lesions, and may also provide new ideas for the precise prevention and treatment of fundus lesions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedApril 9, 2025
October 1, 2024
7 months
March 3, 2025
April 5, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Fundus Fluorescein Angiography (FFA) images with corresponding report
Fundus Fluorescein Angiography(FFA) images with corresponding report were collected. FFA allows dynamic observation of changes in retinal blood vessels and lesions.
Baseline
Indocyanine Green Angiography (ICGA) images with report
Indocyanine Green Angiography (ICGA) images with corresponding report were collected. ICGA allows dynamic observation of changes in choroidal blood vessels and lesions.
Baseline
Fundus photography with corresponding report
Fundus photography images with corresponding report were collected. Fundus photography provides observation of morphological manifestations of the retina, the retinal blood vessels, the optic nerve, as well as lesions on the retina.
Baseline
Optical coherence tomography (OCT) images with corresponding report
Optical coherence tomography (OCT) images with corresponding report were collected. OCT images provides observation of changes in retinal thickness, morphology and manifestations of lesions in each retinal or choroidal layer, as well as lesions in the macular area and optic nerve
Baseline
Optical coherence tomography angiography (OCTA) images with corresponding report
Optical coherence tomography angiography (OCTA) images with corresponding report were collected. OCTA images provides observation of the density, morphology, and manifestations of retinal blood vessels, as well as the morphology and manifestations of retinal lesions
Baseline
Secondary Outcomes (5)
Bilingual Evaluation Understudy (BLEU) analysis
Through study completion, an average of 1 year
Metric for Evaluation of Translation with Explicit Ordering (METEOR) analysis
Through study completion, an average of 1 year
Recall-Oriented Understudy for Gisting Evaluation (ROUGE) analysis
Through study completion, an average of 1 year
Pearson correlation analysis
Through study completion, an average of 1 year
Intersection-Over-Union (IOU) analysis
Through study completion, an average of 1 year
Study Arms (2)
Disease group
With retinal or choroidal diseases
Normal group
Without retinal or choroidal diseases
Interventions
Eligibility Criteria
The clinically collected fundus examination images and corresponding reports, including various categories of fundus lesions or normal findings, obtained from examinations conducted at the Zhongshan Ophthalmic Center.
You may qualify if:
- Disease group: All multimodal fundus examination images containing fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
- Normal group: All multimodal fundus examination images without fundus lesions, examined from January 2011 to December 2023, including fundus photography, as well as OCT, OCTA, FFA, ICGA, B-ultrasound and corresponding imaging reports. Images could be either clear or unclear, reports are either complete or incomplete.
You may not qualify if:
- Disease group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
- Normal group: 1. The image has serious quality problems; 2. The diagnostic report lacks key information.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2025
First Posted
April 9, 2025
Study Start
May 1, 2025
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
April 9, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share